LINC00152 is significantly upregulated in gallbladder cancer, and the upregulation of LINC00152 by SP1 promotes gallbladder cancer cell growth and tumor metastasis by targeting the PI3K/AKT signaling pathway (12). Here, SP1 is linked to neoplasm.